Contact Us News & Media Font Size Home About Us Products Research Responsibility Investor Relations News & Media Careers DAGMAR ROSA-BJÖRKESON Core Strengths Executive Team Executive Committee Mark Trudeau Mark Casey Meredith Fischer Matthew Harbaugh Ron Lloyd Hugh O'Neill Gary Phillips, M.D. Steven Romano, M.D. Dr. Frank Scholz Karen Sheehy Ian Watkins Select Senior Leaders Coleman Lannum Tunde Otulana, M.D. Dagmar Rosa-Björkeson Kathleen Schaefer Board of Directors 150th Anniversary Our Story Inclusion and Diversity Partnering News & Media Blog Patient Stories Careers at Mallinckrodt Community Outreach Investor Relations Dagmar Rosa-Björkeson Senior Vice President, New Product Commercialization Dagmar Rosa-Björkeson is the senior vice president, new product commercialization at Mallinckrodt Pharmaceuticals. She has responsibility for leading a team focused on shaping Mallinckrodt’s development programs and supporting commercialization efforts to ensure high quality product launches that benefit the patient, customer and company needs. Ms. Rosa-Björkeson is a member of Mallinckrodt’s commercial leadership team. Prior to joining Mallinckrodt, Ms. Rosa-Björkeson served as a biotech/biopharmaceuticals and therapeutics leader for Fortune 500 companies such as Baxalta and Novartis, start-ups and agencies. Throughout her career, Ms. Rosa-Björkeson’s leadership has been recognized with several awards and she has been featured in numerous articles. She is a member of Deirdre’s House and the New Jersey City University Foundation’s board of directors. Ms. Rosa-Björkeson holds a bachelor’s and master’s degree in chemistry and an MBA in marketing from the University of Texas-Austin. She is fluent in English and Spanish with basic knowledge of French and Swedish. Back Building On Our Heritage Nearly 150 years of quality, integrity and service. Learn More Our Culture From philanthropic efforts to advocacy initiatives, we are living our hallmarks throughout our communities. Learn How Resources for: Career Seekers Investors Suppliers About Mallinckrodt: About Us Home Investor Relations News & Media Products Research Responsibility Other Links: Blog Calif. Supply Chain Disclosure Contact Us Patents Privacy Policy Safety Data Sheets Terms of Use UK Modern Slavery Act Disclosure Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company. © 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland. Blog LinkedIn + Cookies Policy Mallinckrodt uses cookies to improve and analyze site functionality. Some aspects of the site may not function properly without cookies enabled. To learn more about how we use cookies and how you can change your cookies setting, please read our Privacy Policy. By continuing to browse the site, you are agreeing to accept our use of cookies. I Agree ›